Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050
Abstract. Background:. The epidemiological pattern and disease burden of type 2 diabetes have been shifting in China over the past decades. This analysis described the epidemiological transition of type 2 diabetes in the past three decades and projected the trend in the future three decades in Chin...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-06-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329157347999744 |
|---|---|
| author | Haojie Zhang Qingyi Jia Peige Song Yongze Li Lihua Jiang Xianghui Fu Sheyu Li Jinjiao Li |
| author_facet | Haojie Zhang Qingyi Jia Peige Song Yongze Li Lihua Jiang Xianghui Fu Sheyu Li Jinjiao Li |
| author_sort | Haojie Zhang |
| collection | DOAJ |
| description | Abstract.
Background:. The epidemiological pattern and disease burden of type 2 diabetes have been shifting in China over the past decades. This analysis described the epidemiological transition of type 2 diabetes in the past three decades and projected the trend in the future three decades in China.
Methods:. Age-, sex-, and year-specific incidence, prevalence, death, and disability-adjusted life years (DALYs) for people with 15 years or older and diabetes or high fasting glucose in China and related countries from 1990 to 2021 were obtained from the Global Burden of Disease. We obtained the trends of age-, sex-, and year-specific rates and absolute numbers of incidence, prevalence, deaths, and DALYs attributable to type 2 diabetes in China from 1990 to 2021. Using the Lee–Carter model, we projected the incidence, prevalence, death, and DALYs attributable to type 2 diabetes to 2050 stratified by age and sex.
Results:. The age-standardized incidence of type 2 diabetes was 341.5 per 100,000 persons (1.6 times in 1990) and the age-standardized prevalence was 9.96% (9960.0 per 100,000 persons, 2.5 times in 1990) in China 2021. In 2021, there were 0.9 million deaths and 26.8 million DALYs due to type 2 diabetes or hyperglycemia, as 2.9 and 2.7 times the data in 1990, respectively. The age-standardized rates of type 2 diabetes and hyperglycemia were projected to raise to 449.5 per 100,000 persons for incidence, 18.17% for prevalence, 244.6 per 100,000 persons for death, and 4720.2 per 100,000 persons for DALYs by 2050. The incidence of type 2 diabetes kept growing among individuals under the age of 20 years in the past three decades (128.7 per 100,000 persons in 1990 and 439.9 per 100,000 persons in 2021) and estimating 1870.8 per 100,000 in 2050.
Conclusions:. The incidence, prevalence, and disease burden of type 2 diabetes grew rapidly in China in the past three decades. The prevention of type 2 diabetes in young people and the care for elder adults will be the greatest challenge for the country. |
| format | Article |
| id | doaj-art-2a260f3272cc49b6ac20ddeae7a2f2f0 |
| institution | Kabale University |
| issn | 0366-6999 2542-5641 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj-art-2a260f3272cc49b6ac20ddeae7a2f2f02025-08-20T03:47:21ZengWolters KluwerChinese Medical Journal0366-69992542-56412025-06-01138121447145510.1097/CM9.0000000000003536202506200-00007Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050Haojie Zhang0Qingyi Jia1Peige Song2Yongze Li3Lihua Jiang4Xianghui Fu5Sheyu Li6Jinjiao Li1 Department of Endocrinology and Metabolism, MAGIC China Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China2 Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China3 School of Public Health and Women’s Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China4 Department of Endocrinology and Metabolism and the Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, First Hospital of China Medical University, Shenyang, Liaoning 110001, China5 Teaching & Research Section of General Practice, The General Practice Medical Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China7 Division of Endocrinology and Metabolism, National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan 610041, China1 Department of Endocrinology and Metabolism, MAGIC China Centre, Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, ChinaAbstract. Background:. The epidemiological pattern and disease burden of type 2 diabetes have been shifting in China over the past decades. This analysis described the epidemiological transition of type 2 diabetes in the past three decades and projected the trend in the future three decades in China. Methods:. Age-, sex-, and year-specific incidence, prevalence, death, and disability-adjusted life years (DALYs) for people with 15 years or older and diabetes or high fasting glucose in China and related countries from 1990 to 2021 were obtained from the Global Burden of Disease. We obtained the trends of age-, sex-, and year-specific rates and absolute numbers of incidence, prevalence, deaths, and DALYs attributable to type 2 diabetes in China from 1990 to 2021. Using the Lee–Carter model, we projected the incidence, prevalence, death, and DALYs attributable to type 2 diabetes to 2050 stratified by age and sex. Results:. The age-standardized incidence of type 2 diabetes was 341.5 per 100,000 persons (1.6 times in 1990) and the age-standardized prevalence was 9.96% (9960.0 per 100,000 persons, 2.5 times in 1990) in China 2021. In 2021, there were 0.9 million deaths and 26.8 million DALYs due to type 2 diabetes or hyperglycemia, as 2.9 and 2.7 times the data in 1990, respectively. The age-standardized rates of type 2 diabetes and hyperglycemia were projected to raise to 449.5 per 100,000 persons for incidence, 18.17% for prevalence, 244.6 per 100,000 persons for death, and 4720.2 per 100,000 persons for DALYs by 2050. The incidence of type 2 diabetes kept growing among individuals under the age of 20 years in the past three decades (128.7 per 100,000 persons in 1990 and 439.9 per 100,000 persons in 2021) and estimating 1870.8 per 100,000 in 2050. Conclusions:. The incidence, prevalence, and disease burden of type 2 diabetes grew rapidly in China in the past three decades. The prevention of type 2 diabetes in young people and the care for elder adults will be the greatest challenge for the country.http://journals.lww.com/10.1097/CM9.0000000000003536 |
| spellingShingle | Haojie Zhang Qingyi Jia Peige Song Yongze Li Lihua Jiang Xianghui Fu Sheyu Li Jinjiao Li Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050 Chinese Medical Journal |
| title | Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050 |
| title_full | Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050 |
| title_fullStr | Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050 |
| title_full_unstemmed | Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050 |
| title_short | Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050 |
| title_sort | incidence prevalence and burden of type 2 diabetes in china trend and projection from 1990 to 2050 |
| url | http://journals.lww.com/10.1097/CM9.0000000000003536 |
| work_keys_str_mv | AT haojiezhang incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT qingyijia incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT peigesong incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT yongzeli incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT lihuajiang incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT xianghuifu incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT sheyuli incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 AT jinjiaoli incidenceprevalenceandburdenoftype2diabetesinchinatrendandprojectionfrom1990to2050 |